BioSpace News Archive

Job Trends

What You Need to Know to Become a Medical Science Liaison

BioSpace spoke with Dr. Samuel Dyer, CEO of The MSL Society, to find out everything you need to know to become a medical science liaison.

January 21, 2019
·
2 min read
·
Editorial Team
Drug Development

BerGenBio Announces Start of Phase I Trial Evaluating ADCT-601, a Novel Anti-AXL ADC, in Patients With Advanced Solid Tumours

ADCT-601 uses a proprietary AXL antibody developed by BerGenBio and licensed to ADC Therapeutics for antibody drug conjugate (ADC) development

January 21, 2019
·
4 min read
Deals

Targovax is Invited to Present at Upcoming Investor Conferences

Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that members of its senior management team will present at upcoming investor conferences.

January 21, 2019
·
1 min read
Policy

Vertex Announces European Commission Approval for ORKAMBI® (lumacaftor/ivacaftor) for Treatment of Children with Cystic Fibrosis Aged 2 to 5 Years Old with Most Common Form of the Disease

Lumacaftor/ivacaftor is the first and only approved medicine in Europe to treat the underlying cause of cystic fibrosis for approximately 1,500 children aged 2 to 5 with two copies of the F508del mutation

January 21, 2019
·
5 min read
Policy

/R E P E A T -- Notice to the media - Minister of Health to unveil Canada’s new Food Guide/

The Honourable Ginette Petitpas Taylor, Minister of Health, will unveil Canada’s new Food Guide on Tuesday, January 22, 2019.

January 21, 2019
·
1 min read
Business

Caris Life Sciences Names Chief Communications Officer

Caris Life Sciences® today announced that Srikant (Sri) Ramaswami, has joined the company as Vice President and Chief Communications Officer.

January 21, 2019
·
2 min read
European Update: Spectrum Cannabis enters UK & Poland

High-quality medical cannabis available today in Polish pharmacies; UK presence positions Spectrum to lead in a key emerging market.

January 21, 2019
·
8 min read
BioMidwest

HNC Virtual Solutions Develops Technology-Enabled Solution to Combat Current Opioid Crisis

Video and Consumer Platform and Kiosks Aim to Improve Patient Rehabilitation Rates

January 21, 2019
·
3 min read
Drug Development

Antibe Therapeutics Receives Approval to Initiate Part Two of Phase 2B Dose-Ranging, Efficacy Study for ATB-346

Antibe Therapeutics Inc. is pleased to announce that it has received approval from Health Canada to initiate the second part of its Phase 2B dose-ranging, efficacy study for its lead drug, ATB-346.

January 21, 2019
·
4 min read
Preliminary In Vitro Data on Anaconda Biomed’s Advanced Thrombectomy System Presented at ABC WIN 2019

Novel System Outperforms Competing Thrombectomy Systems in First and Third Pass Revascularization Rates

January 21, 2019
·
2 min read